• No results found

University of Groningen Epigenetic editing Cano Rodriguez, David

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Epigenetic editing Cano Rodriguez, David"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Epigenetic editing

Cano Rodriguez, David

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Cano Rodriguez, D. (2017). Epigenetic editing: Towards sustained gene expression reprogramming in diseases. University of Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Propositions

1) Gene expression reprogramming can be achieved by targeted epigenetic editing of

regulatory regions. (This Thesis)

2) Epigenetic editing is a powerful research tool to study the molecular mechanisms of

epigenetic processes and also a possible biomedical tool towards a cure for the incurable. (This Thesis)

3) Epigenetic editing applications can range from targeted reprogramming of cells via

induced pluripotent stem cells, to specialized cell types for clinical applications, or induction of genes involved in diseases with allelic imbalanced expression, and anticancer therapy. (Chapter 2)

4) The use of different DNA binding domains will allow for synergistic efforts to unravel

the mechanisms for sustained gene expression reprogramming. (This thesis)

5) Despite the advancement in effector domain choices, further research is necessary to

better understand the effect of chromatin microenvironment in the binding of several targeting platforms in order to realize highly reliable epigenetic editing. (Chapter 4)

6) Understanding the dynamics of the chromatin microenvironment is important to

unravel the mechanisms underlying stable gene reprogramming, thus different outcomes for gene expression modulation are dependent on the local chromatin landscape. (Chapter 8)

7) “Protein synthesis is a central problem for the whole of biology, and that it is in all

probability closely related to gene action” Francis Crick.

8) “Sometimes the greatest scientific breakthroughs happen because someone ignores the prevailing pessimism” Nessa Carey

9) “Your genetics load the gun, your lifestyle pulls the trigger” Mehmet Oz

10) Life is completely unpredictable, and so is the Dutch weather

Referenties

GERELATEERDE DOCUMENTEN

Epigenetic gene regulation is mediated by several mechanisms including DNA methylation and the post-translational modifications (PTM) of the histone tails, both of which may

Below we discuss the most used epigenetic effector domains in epigenetic editing (Table 1)... Epigenetic editing tools available. a) Zinc finger proteins can recognize

Specifically in cancer, transcriptional silencing by hypermethylation has been reported for key regu- latory genes related with cell cycle or apoptosis; in this kind of

faster to design and produce a short sgRNA for any given new target sequence compared to ZFPs and TALEs. However, among these technologies, Cas9 is the biggest, around 160

genous gene-targeting with zinc finger proteins in four cell lines. a) Activation of endogenous RASS- F1A in four cancer cell lines (two hypermethylated cell lines

During the screening of the en- tire antibody library on tissue microarrays (TMAs) carrying cancerous and normal formalin-fixed para- ffin-embedded (FFPE) samples (5 samples /tumor

In this study, we were able to silence SPDEF expression in the human alveolar epithelial cell line A549, using a novel strategy: engineered SPDEF targeting ZF proteins

(c) Relati- ve mRNA expression of ICAM1, RASSF1a, EpCAM in HEK293T and A549 cells and (d) PLOD2 in C33a cells, by the indicated dCas9 fusion protein co-transfected with a